Shandong Xinhua Pharmaceutical Company Limited 0719.HK Stock
Shandong Xinhua Pharmaceutical Company Limited Price Chart
Shandong Xinhua Pharmaceutical Company Limited 0719.HK Financial and Trading Overview
Contents
- Shandong Xinhua Pharmaceutical Company Limited Price Chart
- Shandong Xinhua Pharmaceutical Company Limited 0719.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shandong Xinhua Pharmaceutical Company Limited
- Q&A For Shandong Xinhua Pharmaceutical Company Limited Stock
Shandong Xinhua Pharmaceutical Company Limited stock price | 5.6 HKD |
Previous Close | 6.24 HKD |
Open | 6.24 HKD |
Bid | 6.22 HKD x 0 |
Ask | 6.23 HKD x 0 |
Day's Range | 6.21 - 6.36 HKD |
52 Week Range | 3.65 - 17 HKD |
Volume | 3.76M HKD |
Avg. Volume | 7.63M HKD |
Market Cap | 13.26B HKD |
Beta (5Y Monthly) | 0.114176 |
PE Ratio (TTM) | 8.652778 |
EPS (TTM) | 0.76 HKD |
Forward Dividend & Yield | 0.18 (2.84%) |
Ex-Dividend Date | July 15, 2022 |
1y Target Est | N/A |
0719.HK Valuation Measures
Enterprise Value | 4.86B HKD |
Trailing P/E | 8.652778 |
Forward P/E | 20.096773 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.5957134 |
Price/Book (mrq) | 0.97100997 |
Enterprise Value/Revenue | 0.584 |
Enterprise Value/EBITDA | 4.8 |
Trading Information
Shandong Xinhua Pharmaceutical Company Limited Stock Price History
Beta (5Y Monthly) | 0.114176 |
52-Week Change | 12.23% |
S&P500 52-Week Change | 20.43% |
52 Week High | 17 HKD |
52 Week Low | 3.65 HKD |
50-Day Moving Average | 6.4 HKD |
200-Day Moving Average | 6.26 HKD |
0719.HK Share Statistics
Avg. Volume (3 month) | 7.63M HKD |
Avg. Daily Volume (10-Days) | 2.73M HKD |
Shares Outstanding | 195M |
Float | 415.38M |
Short Ratio | N/A |
% Held by Insiders | 10.68% |
% Held by Institutions | 1.33% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.2 |
Trailing Annual Dividend Yield | 3.20% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2292 |
Last Split Factor | 13:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 5.46% |
Operating Margin (ttm) | 6.20% |
Gross Margin | 27.86% |
EBITDA Margin | 12.17% |
Management Effectiveness
Return on Assets (ttm) | 4.11% |
Return on Equity (ttm) | 10.95% |
Income Statement
Revenue (ttm) | 8.31B HKD |
Revenue Per Share (ttm) | 12.48 HKD |
Quarterly Revenue Growth (yoy) | 44.10% |
Gross Profit (ttm) | N/A |
EBITDA | 1.01B HKD |
Net Income Avi to Common (ttm) | 454.29M HKD |
Diluted EPS (ttm) | 0.72 |
Quarterly Earnings Growth (yoy) | 39.70% |
Balance Sheet
Total Cash (mrq) | 863.7M HKD |
Total Cash Per Share (mrq) | 1.28 HKD |
Total Debt (mrq) | 1.34B HKD |
Total Debt/Equity (mrq) | 29.4 HKD |
Current Ratio (mrq) | 1.468 |
Book Value Per Share (mrq) | 6.416 |
Cash Flow Statement
Operating Cash Flow (ttm) | 592.21M HKD |
Levered Free Cash Flow (ttm) | 560.95M HKD |
Profile of Shandong Xinhua Pharmaceutical Company Limited
Country | Hong Kong |
State | N/A |
City | Zibo |
Address | Chemical Industry Area |
ZIP | 255005 |
Phone | 86 53 3216 6666 |
Website | https://www.xhzy.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
Q&A For Shandong Xinhua Pharmaceutical Company Limited Stock
What is a current 0719.HK stock price?
Shandong Xinhua Pharmaceutical Company Limited 0719.HK stock price today per share is 5.6 HKD.
How to purchase Shandong Xinhua Pharmaceutical Company Limited stock?
You can buy 0719.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shandong Xinhua Pharmaceutical Company Limited?
The stock symbol or ticker of Shandong Xinhua Pharmaceutical Company Limited is 0719.HK.
Which industry does the Shandong Xinhua Pharmaceutical Company Limited company belong to?
The Shandong Xinhua Pharmaceutical Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shandong Xinhua Pharmaceutical Company Limited have in circulation?
The max supply of Shandong Xinhua Pharmaceutical Company Limited shares is 1.68B.
What is Shandong Xinhua Pharmaceutical Company Limited Price to Earnings Ratio (PE Ratio)?
Shandong Xinhua Pharmaceutical Company Limited PE Ratio is 7.36842100 now.
What was Shandong Xinhua Pharmaceutical Company Limited earnings per share over the trailing 12 months (TTM)?
Shandong Xinhua Pharmaceutical Company Limited EPS is 0.76 HKD over the trailing 12 months.
Which sector does the Shandong Xinhua Pharmaceutical Company Limited company belong to?
The Shandong Xinhua Pharmaceutical Company Limited sector is Healthcare.